HA Central Register of Clinical Research 1 Dec 04 HA REC.

Slides:

Advertisements

Similar presentations

Chiari Surgical Outcomes Trial PI: Bermans J. Iskandar and Timothy George with collaboration from John Kestle ASAP-funded pilot study ASAP-funded pilot.

Advertisements

The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.

Research Policy & Management RACD INTRODUCTION TO RESEARCH GOVERNANCE.

Tips to a Successful Monitoring Visit

Medication Management

The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)

A university wide electronic research ethics review system?

New Trials If you are seeking a collaboration with the UCL CCTU we require you to apply: At least 3 months before the application deadline By using the.

Bev White, Manager, Research Ethics Research Services, IWK Health Centre.

Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.

Managing Sponsorship Research Services University of Oxford.

How does the process work? Submissions in 2007 (n=13,043) Perspectives.

Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.

NSF Data Management Plan Requirements Alex Kanous

 About SP ERC  Role of SP ERC  SP ERC Members  ERC Operations  Definition of Research  Definition of Principal Investigator (PI), Co-PI, Collaborator.

Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.

Jasper Ogwal-Okeng Gulu University Research Workshop 3 rd -6 th March 08.

Document Development for Research Ethics Clinical Effectiveness Unit Division, PS & MD 2005.

Retha Britz Copyright 2013 All rights reserved for this presentation 1 Establishment and functioning of a REC Retha Britz.

Andrew Thornton, Chairman, RAH HREC

Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.

Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.

Title Name Institute. Background -1 (Main problem)

CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.

GCP & ETHICS COMMITTEES Ravi Rengachari Vector Control Research Centre PONDICHERRY.

The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.

TERRENCE F. ACKERMAN, PH.D. PROFESSOR OF BIOETHICS CHAIR, UTHSC IRB.

IWK Research Ethics - Workshop Series Session #2 REB Review Procedures How to submit … October 24, 2013 Bev White, Manager, Research Ethics Research Services,

SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.

Overview of FDA's Regulatory Framework for PET Drugs

Leslie Howes, MPH, CIP Alyssa Speier, MS, CIP September 24, 2014 Investigator Manual: ra/investigator-manual/

Presented at the Arthritis Advisory Committee meeting on July 15, 2003 by Hugh Davies, M.D.

HA Research Ethics Development HA REC Meeting 6/2/2004 HA REC Meeting 6/2/2004.

Melissa McCarey, MPH Jefferson Clinical Research Institute (JCRI) Clinicaltrials.gov: What is it? What do I need to know?

How to Start An Industry Sponsored Clinical Trial

APPROVAL CRITERIA AN IRB INFOSHORT MAY CFR CRITERIA FOR IRB APPROVAL OF RESEARCH In order for an IRB to approve a research study, all.

Office of Human Research Protection Georgia Health Sciences University.

Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.

Sponsor Visits and Monitoring

NCI Clinical Trials Reporting Program CTRP User Meeting June 6, 2012 Gene Kraus CTRP Program Director.

INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC)

IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.

Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.

GCP (GOOD CLINICAL PRACTISE)

Responsibilities of Sponsor, Investigator and Monitor

Audit on herbal study protocols reviewed by an Ethics Review Committee of a Western Medical Institution Wanigatunge CA, Warnacula G, Prathapan S Ethics.

Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.

Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.

Design of Case Report Forms

National Institute for Medical Research

NIH/AHRQ/NIOSH UPDATES effective January 25, 2017

FDAAA Clinical Trial Disclosure Briefing for GCP/QA SIAC

COCE Institutional Review Board Academic Spotlight

IRB BASICS Ethics and Human Subject Protections Summer 2016

Responsibilities of Sponsor, Investigator and Monitor

MAINTAINING THE INVESTIGATOR’S SITE FILE

Clinicaltrials.gov Update

What is a Data and Safety Monitoring Plan and how do I get one?

Alyssa Speier, MS, CIP November 13, 2013

Decision Tree for eIRB Submission Revised: 01/12/2016

REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.

To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.

IRB BASICS: Ethics and Human Subject Protections

Overview of Important Changes to the Final Rule

HREC Operating Procedures for the Review of Low and Moderate to High Risk Projects

eResearch at Emory Phase I: eIRB

Overview of Important Changes to the Final Rule

Cindy Murray NP Princess Margaret Cancer Centre

Research, Experimentation, & Clinical Trials

S A Overarching SOPs Funding Secured Training Records

Presentation transcript:

HA Central Register of Clinical Research 1 Dec 04 HA REC

Objectives  Collect data on investigational articles of clinical trials involving HA (facilitate safety alert / recall & related PA issues)  Provide an overview of ongoing clinical research activities within HA (sourcing review process of insurers)  Monitor trend of clinical research activities within HA & plan for required support

Considerations  HA REC endorsement  Acknowledge investigators by stating in application form  Administration have to ensure confidentiality  Cluster REC/IRB has to inform HA REC before accessing the data  Reporting mechanism to HA REC

Data  Contains 31 items obtained from the Clinical Research Ethics Review Application Form  HAREC collects data in monthly basis  Yearly report to HAREC members  Access to the database is restricted to the secretary of HAREC & personnel for administrative support

Contents of HA Central Register of Clinical Research (31 items) 1. Application reference number16. Study design 2. Name of Research Ethics Committee17. Investigational article 3. Study Title18. Is the test drug licensed in HK 4. Principal Investigator (PI) Title; Surname; Other name & primary institution 19. Is the study involve an additional invasive procedure 5. Is the PI a Hospital Authority (HA) staff20. Is there an independent data monitoring committee 6. Is the study a single or multi centre trial21. Primary source of funding 7. Specialty involved in study site22. Any fee income to hospital 8. Primary study site23. The alternative source of income (if applicable) 9. Is the study an international study24. Is there a external/indemnity insurance provided 10. Proposed study start date25. Phase of trial 11. Initial intended completion date26. Protocol submission date 12. Final report receipt date27. Date of REC review decision 13. Is the research a cross-cluster study with approval by another REC28. REC review decision 29. Reason for REC disapproval (if applicable) 14. Reference number of the protocol approved by another REC (if applicable) 30. Date of premature termination of study 15. Maximum number of participants/samples/records planned (local)31. Reason for premature termination

Database entry template

Datasheet template (Entry Form 1)

Datasheet template (Entry Form 2)

Datasheet template (Entry Form 3)

Datasheet template (Entry Form 4)